high quality MT-1 Peptide CAS-75921-69-6 purity >99% factory selling in stock Lyophilized powder

     Core Effects
     The core effects of the MT1 receptor revolve around its precise regulation of sleep and the biological clock. Specifically, these effects are manifested in the following  aspects:
     Regulate the circadian rhythm and induce sleep onset: After the MT1 receptor is activated, it can inhibit the neuronal activity of the suprachiasmatic nucleus, helping to regulate the sleep and wake cycle, thereby shortening the sleep onset time, prolonging the sleep duration, and improving the sleep quality.
It is mainly responsible for adjusting the phase change at the beginning of the circadian rhythm and regulating the light cycle information.

     Treatment of insomnia disorder: Due to the central role of the MT1 receptor in regulating sleep, it has become an important drug target for treating insomnia (especially insomnia that is difficult to fall asleep).
     Selective MT1/MT2 receptor (such as ramelteon) activate the MT1 receptor with high affinity, resulting in sleep-promoting effects while avoiding the side effects associated with traditional sedative-hypnotic drugs, such as distraction, drug addiction, and dependence.

     Improving mood disorders: The MT1 receptor is also related to mood regulation. For instance, agomelatine, which has both MT1/MT2 receptor and 5-HT2C receptor effects, is used as an antidepressant and can improve insomnia associated with depressive disorders.
     Provide more precise treatment plans: Compared to directly supplementing exogenous melatonin, drugs targeting the MT1 receptor can achieve more precise biological benefits, avoiding the uncertainties and potential safety risks associated with direct  supplementation.
     These drugs offer a clinically promising solution with broad application prospects for treating sleep disorders caused by circadian rhythm disorders.
     It should be noted that long-term and high-dose use of melatonin may lead to a "desensitization" phenomenon in the MT1 receptor, resulting in a decrease in receptor activity.
     Therefore, drugs specifically targeting the MT1 receptor mechanism, based on this mechanism, may theoretically offer more stable and prolonged therapeutic effect.

     Hongbai Technology Co., Ltd. is  a branch of Changsha Dolo Technology Co., Ltd.，which is a pioneering force in the biotechnology sector.

     At the core of our operations is the unwavering commitment to our guiding principles : "Quality First, Service Supreme."Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.

     Our primary focus encompasses a range of products , including weight loss peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Tirzepatide, Retatrutide, and others.Provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the Clients.We have professional sales team , focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market, our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.

     With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers .